Observational study to see how long the SARS CoV-2 virus remains alive in the nose and throat of cancer patients on chemotherapy
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: C00-D49- Neoplasms
- Registration Number
- CTRI/2021/04/033068
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Oncology patients admitted with RT-PCR confirmed COVID-19 illness
2. Age 1 to 80 years
3. Patients willing to consent for additional blood and nasopharyngeal swabs.
Exclusion Criteria
1. ICU patients unable to give nasopharyngeal swab or blood sample for study proposes
2. Patients with other inter-current bacterial viral respiratory infections.
3. Patients in palliative therapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determine the duration of persistence of replication-competent/infectious virus in oncology patients.Timepoint: At the baseline and at the time repeat nasopharyngeal swab if required as per standard reassessment
- Secondary Outcome Measures
Name Time Method